Yale study finds Black children most likely to be physically restrained in emergency department visits
A new paper by Yale researchers finds racial disparities in the use of physical restraints on children who are admitted to the emergency department. Black children are more likely than White children to be subdued with restraints during ED visits, the study finds. Published September 13 in JAMA Pediatrics, the study looked at data from 11 EDs across New England between 2013 and 2020. Their sample included over 551,000 visits of patients ages 0 to 16, in which physical restraints were used 532 times. According to their analysis, Black pediatric patients were 1.8 times more likely to receive a physical restraint than a White patient. Boys were more likely than girls to be restrained. The results mirror those in another Yale-led study that looked at the use of restraints on adults in the ED, and found that Black males who lacked insurance were more likely than patients of other racial demographics to be physically restrained.
Are nonprofit hospitals holding up their end of the tax-free bargain?
Tax exemptions are estimated to save nonprofit hospitals over $24 billion annually. In return, the hospitals are expected to invest these would-be tax dollars into caring for underserved patients (“charity care”) and improving the health of their communities.Source: The Hill
Biden Announces New COVID-19 Vaccination Initiatives and Mandates
President Joe Biden announced new vaccination incentives and mandates this Thursday,1 stressing the need to depoliticize vaccinations and avoid moving backward in the course of the pandemic. “Look, this is not about red states and blue states,” Biden said. “It’s literally about life and death.”Source: Very Well Health
Opinion: The FDA is in desperate need of some soul-searching
Ordinarily, the approval of a new drug for a dreaded disease affecting millions of Americans would be a cause for celebration. But aducanumab, which the Food and Drug Administration approved last week to treat Alzheimer’s disease, is no ordinary drug. It encapsulates everything that ails the regulation of the pharmaceutical industry and is a grim reminder of the soul-searching about the FDA’s integrity that’s desperately needed.Source: The Washington Post
New Alzheimer's drug sets dangerous precedent
Last week, the US Food and Drug Administration (FDA) approved aducanumab as a treatment for Alzheimer's disease -- a historic decision not because it addresses the longstanding need for a safe and effective cure of a devastating disease that affects nearly 6 million Americans, but because of the unprecedented irregularities of the agency's actions, undermining its mission to protect public health and ensure the "safety, efficacy, and security" of treatments made available in the United States.Source: CNN
COVID-19 lesson: New FDA chief, when chosen, must crack down on clinical trial transparency
The COVID-19 pandemic has reinforced the importance of the Food and Drug Administration (FDA) in instilling trust in authorized and approved therapies and vaccines. Recent, repeated missteps from AstraZeneca surrounding its characterization of COVID-19 vaccine trial results, as well as possible safety concerns, have led to a clamoring call for increased FDA scrutiny of and transparency around AstraZeneca’s clinical trial data.Source: The Baltimore Sun
What is Health Equity?
Health equity means that everyone has a fair and just opportunity to live their healthiest lives possible. If that sounds like a no-brainer, it may be surprising to learn just how much disparity exists in health outcomes and access to treatment at a societal level.Source: YaleNews
Study Finds Prolonged and Inequitable Length of Stay in Emergency Department for Children Seeking Mental Health Care
The length of time that children and teens spend in an emergency department for a mental health issue has increased over time, and Hispanic children are nearly three times as likely to have a prolonged visit than non-Hispanic children, according to a Pediatrics study.Source: AAP News
Diversifi: Changing the Face of Healthcare
With their aim of increasing diversity in the medical field, the Diversifi team tackles structural racism in healthcare from multiple angles: the initiative helps make these careers more accessible to underrepresented groups, as well as supports the growth of a workforce that is more capable of providing unbiased healthcare to these populations.
Is it time to consider social determinants of health in Medicare payments?
Eta was a 76-year-old woman with a recent heart attack in and out of the hospital over the last several months. Her course had been complicated by social determinants of health, in that she lacked reliable transportation for necessary follow-up, had unstable housing, and her insurance did not cover valuable care from home health agencies. These obstacles made it difficult for her and her doctors to ensure that she recovered. As a geriatrics researcher and emergency physician, I have coordinated care for Medicare patients like Eta, to ensure they get the additional services they need. However, clinicians are often seemingly punished by reduced Medicare reimbursements when caring for these patients, thereby often creating a perverse disincentive to help this population most at need and potentially exacerbating health disparities.Source: KevinMD.com
It was 2013. Margi Rosenthal and I were sitting side-by-side at a large meeting table, surrounded by staff from a local non-profit organization dedicated to violence prevention and family advocacy. She was the co-director of the National Clinician Scholars Program and was leading a National Institutes of Health (NIH)-funded study on youth violence prevention. I was a new arrival in town, having just started my pediatric emergency medicine fellowship at Yale. She had brought me along to learn more, and I was hoping to assist in the project.
Though I only knew Margi for a few years, her mentorship and belief in me will have a lasting impact on who I am as a pediatrician, community member, and writer. I have seen how one person can connect with a community in such a deep and meaningful way through her actions, her words, and now her memory. I am forever thankful.
Opinion: In memory of a fierce advocate for New Haven children
2020 has taken a lot of people from us. People we’ve loved (200,000 deaths from COVID and counting), people we admired (Justice Ginsberg, Congressman John Lewis, the Rev. C.T. Vivian), and people we may not have known, but whose death shook us (George Floyd, Breonna Taylor, Ahmaud Arbery). In the middle of so much loss, the deaths of many people who spent their lives working hard in the background may be overlooked. Dr. Margi Rosenthal cannot be one of those people.Source: The New Haven Register
Does Remdesivir Actually Work Against Covid-19?
When the Food and Drug Administration approves a new treatment or vaccine, as doctors we are assured that rigorous studies have proven it to be safe and effective. But the F.D.A.’s haphazard issuance of emergency use authorizations for Covid-19 treatments like hydroxychloroquine and convalescent plasma, whose potential benefits have not yet been backed up by data, has undermined this trust.Source: The New York Times
During the debate, President Trump said he’s ‘cutting drug prices.’ He’s not.
Amid the chaos of the first presidential debate, President Trump touted his record on a critical issue for many, including my patients — the exorbitant prices of prescription drugs. According to a 2019 national survey, about a quarter of Americans had difficulty affording their medicines. Almost one-third of U.S. adults also reported medication rationing, often skipping doses or taking less because of high prices. COVID-19 has compounded this dire situation, as lost wages and unemployment have forced patients like mine to choose between medicine and groceries.Source: Sun Sentinel